down arrow

PAUL HARTMANN AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0007474041
  • FRA: PHH2
EUR
196.00
0.5 (0.26%)

Oct 02

FRA

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PAUL HARTMANN AG stock-summary
stock-summary
PAUL HARTMANN AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
444 Million
(Quarterly Results - Mar 2013)
Net Profit:
14 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 700 Million ()

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.13%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

4.12%

stock-summary
Price to Book

0.57

Footer loading